{"hands_on_practices": [{"introduction": "The cornerstone of evaluating any new diagnostic test is to quantify its performance against an established reference standard, a process that commonly results in a $2 \\times 2$ contingency table. From this table, we can derive the most fundamental metrics of diagnostic accuracy, which are essential for clinical interpretation and regulatory approval. This exercise guides you through the calculation of sensitivity, specificity, positive and negative predictive values, and overall accuracy, and importantly, demonstrates how to quantify the statistical uncertainty in these point estimates using Wilson score confidence intervals [@problem_id:2524028].", "problem": "A clinical microbiology laboratory evaluates a new real-time Polymerase Chain Reaction (PCR) assay for rapid detection of a bloodstream pathogen, using aerobic blood culture as the reference standard. Over a defined evaluation period, the assay and the reference standard are applied in parallel to the same set of patient specimens. The resulting $2\\times 2$ confusion matrix yields the following counts: true positives (TP) $= 94$, false positives (FP) $= 6$, false negatives (FN) $= 10$, and true negatives (TN) $= 890$. Using the foundational definitions of diagnostic performance in microbial diagnostics, where sensitivity is the probability of a positive test among infected individuals, specificity is the probability of a negative test among uninfected individuals, Positive Predictive Value (PPV) is the probability of infection given a positive test, Negative Predictive Value (NPV) is the probability of no infection given a negative test, and overall accuracy is the probability the test result matches the reference standard, compute the point estimates of sensitivity, specificity, PPV, NPV, and accuracy.\n\nThen, for each of these five proportions, construct the Wilson score interval at $95\\%$ confidence rooted in the binomial model for counts, without continuity correction. Round all reported values (point estimates and each confidence bound) to four significant figures. Express the final values as unitless decimals (do not use percentage notation). Your final answer must list, in this exact order, the $15$ numbers: sensitivity, its lower and upper confidence bounds, specificity, its lower and upper confidence bounds, PPV, its lower and upper confidence bounds, NPV, its lower and upper confidence bounds, accuracy, its lower and upper confidence bounds.", "solution": "The problem statement has been subjected to rigorous validation prior to any attempt at a solution.\n\nThe givens are the counts from a $2 \\times 2$ confusion matrix for a diagnostic test evaluation:\n- True Positives ($TP$) $= 94$\n- False Positives ($FP$) $= 6$\n- False Negatives ($FN$) $= 10$\n- True Negatives ($TN$) $= 890$\n\nThe task is to compute point estimates and $95\\%$ Wilson score confidence intervals for five standard performance metrics: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy.\n\nThis problem is scientifically grounded, well-posed, and objective. It presents a complete and consistent dataset typical of a clinical microbiology study. The definitions provided are standard, and the statistical methods stipulated are appropriate and unambiguous. No scientific, logical, or structural flaws are present. Therefore, the problem is ruled valid, and we proceed with a formal derivation of the solution.\n\nFirst, we establish the necessary totals from the given counts. The population is stratified by the reference standard (true condition) and the new test's results.\n- Total with the condition (Infected): $P = TP + FN = 94 + 10 = 104$.\n- Total without the condition (Uninfected): $N = TN + FP = 890 + 6 = 896$.\n- Total positive test results: $T_{P} = TP + FP = 94 + 6 = 100$.\n- Total negative test results: $T_{N} = TN + FN = 890 + 10 = 900$.\n- Total population: $S = TP + FP + FN + TN = 94 + 6 + 10 + 890 = 1000$.\n\nFor each metric, we will calculate the point estimate, $\\hat{p}$, and its $95\\%$ Wilson score confidence interval $(L, U)$. The Wilson interval for a proportion $\\hat{p} = k/n$ (where $k$ is the number of successes in $n$ trials) is given by:\n$$ (L, U) = \\frac{1}{1 + \\frac{z^2}{n}} \\left( \\hat{p} + \\frac{z^2}{2n} \\pm z \\sqrt{\\frac{\\hat{p}(1-\\hat{p})}{n} + \\frac{z^2}{4n^2}} \\right) $$\nFor a $95\\%$ confidence level, $\\alpha = 0.05$, and the standard normal variate is $z = z_{1-\\alpha/2} = z_{0.975} \\approx 1.959964$. All final values must be rounded to four significant figures.\n\n1. Sensitivity (Sens)\nSensitivity is the proportion of correctly identified positives among all individuals with the condition.\n- Point Estimate: $Sens = \\frac{TP}{TP+FN} = \\frac{94}{104} \\approx 0.903846 \\ldots$\nRounded to four significant figures, $Sens = 0.9038$.\n- Wilson Interval: Here, $k = 94$ and $n = 104$.\nThe resulting interval is $[0.831988\\ldots, 0.946928\\ldots]$.\nLower bound, $L_{Sens} = 0.8320$.\nUpper bound, $U_{Sens} = 0.9469$.\n\n2. Specificity (Spec)\nSpecificity is the proportion of correctly identified negatives among all individuals without the condition.\n- Point Estimate: $Spec = \\frac{TN}{TN+FP} = \\frac{890}{896} \\approx 0.993303 \\ldots$\nRounded to four significant figures, $Spec = 0.9933$.\n- Wilson Interval: Here, $k = 890$ and $n = 896$.\nThe resulting interval is $[0.985472\\ldots, 0.996928\\ldots]$.\nLower bound, $L_{Spec} = 0.9855$.\nUpper bound, $U_{Spec} = 0.9969$.\n\n3. Positive Predictive Value (PPV)\nPPV is the proportion of true positives among all individuals with a positive test result.\n- Point Estimate: $PPV = \\frac{TP}{TP+FP} = \\frac{94}{100} = 0.94$.\nAs a decimal with four significant figures, $PPV = 0.9400$.\n- Wilson Interval: Here, $k = 94$ and $n = 100$.\nThe resulting interval is $[0.875231\\ldots, 0.972210\\ldots]$.\nLower bound, $L_{PPV} = 0.8752$.\nUpper bound, $U_{PPV} = 0.9722$.\n\n4. Negative Predictive Value (NPV)\nNPV is the proportion of true negatives among all individuals with a negative test result.\n- Point Estimate: $NPV = \\frac{TN}{TN+FN} = \\frac{890}{900} \\approx 0.988888 \\ldots$\nRounded to four significant figures, $NPV = 0.9889$.\n- Wilson Interval: Here, $k = 890$ and $n = 900$.\nThe resulting interval is $[0.979671\\ldots, 0.993949\\ldots]$.\nLower bound, $L_{NPV} = 0.9797$.\nUpper bound, $U_{NPV} = 0.9939$.\n\n5. Accuracy (Acc)\nAccuracy is the proportion of correct results (both true positives and true negatives) among the total population.\n- Point Estimate: $Acc = \\frac{TP+TN}{TP+FP+FN+TN} = \\frac{94+890}{1000} = \\frac{984}{1000} = 0.984$.\nAs a decimal with four significant figures, $Acc = 0.9840$.\n- Wilson Interval: Here, $k = 984$ and $n = 1000$.\nThe resulting interval is $[0.974168\\ldots, 0.990126\\ldots]$.\nLower bound, $L_{Acc} = 0.9742$.\nUpper bound, $U_{Acc} = 0.9901$.\n\nThe final set of $15$ requested values, rounded to four significant figures, is now compiled.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.9038 & 0.8320 & 0.9469 & 0.9933 & 0.9855 & 0.9969 & 0.9400 & 0.8752 & 0.9722 & 0.9889 & 0.9797 & 0.9939 & 0.9840 & 0.9742 & 0.9901\n\\end{pmatrix}\n}\n$$", "id": "2524028"}, {"introduction": "Many modern diagnostic assays produce a continuous score rather than a simple binary result, requiring the selection of a cutoff threshold to classify specimens as positive or negative. The choice of this threshold fundamentally determines the test's performance, creating a trade-off between correctly identifying true positives (sensitivity) and true negatives (specificity). This practice explores the theoretical foundation of this trade-off by deriving the optimal threshold that maximizes the Youden index, a common performance metric, under a standard statistical model of normally distributed biomarker values [@problem_id:2523986].", "problem": "A continuous molecular assay used in microbial diagnostics produces a scalar score $X$ for each specimen. Higher values of $X$ are biologically associated with the presence of a target pathogen. Suppose the distribution of $X$ among truly diseased specimens is normal with common standard deviation, $X \\mid \\text{diseased} \\sim \\mathcal{N}(\\mu_{D}, \\sigma^{2})$, and among truly non-diseased specimens is $X \\mid \\text{non-diseased} \\sim \\mathcal{N}(\\mu_{N}, \\sigma^{2})$, with $\\mu_{D} > \\mu_{N}$ and $\\sigma > 0$. Consider the decision rule that classifies a specimen as test-positive if $X \\ge \\tau$ and test-negative otherwise, for a threshold $\\tau \\in \\mathbb{R}$.\n\nUsing only the core definitions of sensitivity, specificity, the Youden index, and well-tested properties of the normal distribution and its standardization (in particular, the standard normal cumulative distribution function and its derivative), derive from first principles the threshold $\\tau^{\\star}$ that maximizes the Youden index $J(\\tau)$, where $J(\\tau) \\equiv \\text{sensitivity}(\\tau) + \\text{specificity}(\\tau) - 1$. Then, express the sensitivity and specificity attained at $\\tau^{\\star}$ in closed form.\n\nProvide your final result as a single row matrix containing, in order, $\\tau^{\\star}$, $\\text{sensitivity}(\\tau^{\\star})$, and $\\text{specificity}(\\tau^{\\star})$, each expressed in terms of $\\mu_{D}$, $\\mu_{N}$, $\\sigma$, and the standard normal cumulative distribution function $\\Phi(\\cdot)$. No numerical evaluation is required, and no rounding is needed. Do not include units.", "solution": "The problem concerns classification based on a continuous diagnostic score $X$ under equal-variance normal models. We begin from the core definitions:\n\n- Sensitivity at a threshold $\\tau$ is the true positive probability,\n$$\n\\text{Se}(\\tau) \\equiv \\mathbb{P}(X \\ge \\tau \\mid \\text{diseased}).\n$$\n\n- Specificity at a threshold $\\tau$ is the true negative probability,\n$$\n\\text{Sp}(\\tau) \\equiv \\mathbb{P}(X < \\tau \\mid \\text{non-diseased}).\n$$\n\n- The Youden index at threshold $\\tau$ is\n$$\nJ(\\tau) \\equiv \\text{Se}(\\tau) + \\text{Sp}(\\tau) - 1.\n$$\n\nUnder the assumptions $X \\mid \\text{diseased} \\sim \\mathcal{N}(\\mu_{D}, \\sigma^{2})$ and $X \\mid \\text{non-diseased} \\sim \\mathcal{N}(\\mu_{N}, \\sigma^{2})$ with $\\mu_{D} > \\mu_{N}$, and using the standard normal cumulative distribution function $\\Phi(\\cdot)$ and its density $\\phi(\\cdot)$, we can express sensitivity and specificity via normal standardization.\n\nFor sensitivity,\n$$\n\\text{Se}(\\tau) = \\mathbb{P}(X \\ge \\tau \\mid \\text{diseased})\n= \\mathbb{P}\\!\\left(\\frac{X - \\mu_{D}}{\\sigma} \\ge \\frac{\\tau - \\mu_{D}}{\\sigma} \\,\\middle|\\, \\text{diseased}\\right)\n= 1 - \\Phi\\!\\left(\\frac{\\tau - \\mu_{D}}{\\sigma}\\right)\n= \\Phi\\!\\left(\\frac{\\mu_{D} - \\tau}{\\sigma}\\right),\n$$\nwhere we used the symmetry property $\\Phi(-z) = 1 - \\Phi(z)$.\n\nFor specificity,\n$$\n\\text{Sp}(\\tau) = \\mathbb{P}(X < \\tau \\mid \\text{non-diseased})\n= \\mathbb{P}\\!\\left(\\frac{X - \\mu_{N}}{\\sigma} < \\frac{\\tau - \\mu_{N}}{\\sigma} \\,\\middle|\\, \\text{non-diseased}\\right)\n= \\Phi\\!\\left(\\frac{\\tau - \\mu_{N}}{\\sigma}\\right).\n$$\n\nTherefore,\n$$\nJ(\\tau) = \\Phi\\!\\left(\\frac{\\mu_{D} - \\tau}{\\sigma}\\right) + \\Phi\\!\\left(\\frac{\\tau - \\mu_{N}}{\\sigma}\\right) - 1.\n$$\n\nTo maximize $J(\\tau)$ over $\\tau \\in \\mathbb{R}$, we differentiate with respect to $\\tau$ and set the derivative to zero. Using the chain rule and the fact that $\\frac{d}{dz}\\Phi(z) = \\phi(z)$, we obtain\n$$\n\\frac{d}{d\\tau} J(\\tau)\n= -\\frac{1}{\\sigma}\\,\\phi\\!\\left(\\frac{\\mu_{D} - \\tau}{\\sigma}\\right)\n+ \\frac{1}{\\sigma}\\,\\phi\\!\\left(\\frac{\\tau - \\mu_{N}}{\\sigma}\\right).\n$$\nSetting $\\frac{d}{d\\tau}J(\\tau) = 0$ yields\n$$\n\\phi\\!\\left(\\frac{\\tau - \\mu_{N}}{\\sigma}\\right)\n= \\phi\\!\\left(\\frac{\\mu_{D} - \\tau}{\\sigma}\\right).\n$$\n\nSince $\\phi(z) = \\frac{1}{\\sqrt{2\\pi}} \\exp\\!\\left(-\\frac{z^{2}}{2}\\right)$ is strictly decreasing in $|z|$ and strictly positive, equality holds if and only if the arguments have equal squared magnitude, that is,\n$$\n\\left(\\frac{\\tau - \\mu_{N}}{\\sigma}\\right)^{2} = \\left(\\frac{\\mu_{D} - \\tau}{\\sigma}\\right)^{2}\n\\quad \\Longleftrightarrow \\quad\n(\\tau - \\mu_{N})^{2} = (\\mu_{D} - \\tau)^{2}.\n$$\nTaking square roots gives two algebraic possibilities:\n$$\n\\tau - \\mu_{N} = \\mu_{D} - \\tau\n\\quad \\text{or} \\quad\n\\tau - \\mu_{N} = -(\\mu_{D} - \\tau).\n$$\nThe second condition simplifies to $\\mu_{N} = \\mu_{D}$, which contradicts the assumption $\\mu_{D} > \\mu_{N}$. Therefore, the only admissible solution is\n$$\n\\tau^{\\star} = \\frac{\\mu_{D} + \\mu_{N}}{2}.\n$$\n\nTo ensure that $\\tau^{\\star}$ maximizes $J(\\tau)$, observe that $\\lim_{\\tau \\to -\\infty} J(\\tau) = 0$ and $\\lim_{\\tau \\to +\\infty} J(\\tau) = 0$, while $J(\\tau)$ is continuous and differentiable with a unique interior critical point; hence the critical point is the global maximizer.\n\nNext, compute the sensitivity and specificity at $\\tau^{\\star}$. Define the mean separation $\\Delta \\equiv \\mu_{D} - \\mu_{N} > 0$. Then\n$$\n\\text{Se}(\\tau^{\\star})\n= \\Phi\\!\\left(\\frac{\\mu_{D} - \\tau^{\\star}}{\\sigma}\\right)\n= \\Phi\\!\\left(\\frac{\\mu_{D} - \\frac{\\mu_{D} + \\mu_{N}}{2}}{\\sigma}\\right)\n= \\Phi\\!\\left(\\frac{\\mu_{D} - \\mu_{N}}{2\\sigma}\\right)\n= \\Phi\\!\\left(\\frac{\\Delta}{2\\sigma}\\right),\n$$\nand\n$$\n\\text{Sp}(\\tau^{\\star})\n= \\Phi\\!\\left(\\frac{\\tau^{\\star} - \\mu_{N}}{\\sigma}\\right)\n= \\Phi\\!\\left(\\frac{\\frac{\\mu_{D} + \\mu_{N}}{2} - \\mu_{N}}{\\sigma}\\right)\n= \\Phi\\!\\left(\\frac{\\mu_{D} - \\mu_{N}}{2\\sigma}\\right)\n= \\Phi\\!\\left(\\frac{\\Delta}{2\\sigma}\\right).\n$$\n\nThus, at the Youden index maximizing threshold, sensitivity and specificity are equal and are both given by the standard normal cumulative distribution function evaluated at the standardized half-separation of the class means.\n\nCollecting the required quantities in the specified order, we have\n$$\n\\tau^{\\star} = \\frac{\\mu_{D} + \\mu_{N}}{2}, \\quad\n\\text{Se}(\\tau^{\\star}) = \\Phi\\!\\left(\\frac{\\mu_{D} - \\mu_{N}}{2\\sigma}\\right), \\quad\n\\text{Sp}(\\tau^{\\star}) = \\Phi\\!\\left(\\frac{\\mu_{D} - \\mu_{N}}{2\\sigma}\\right).\n$$", "answer": "$$\\boxed{\\begin{pmatrix}\\frac{\\mu_{D}+\\mu_{N}}{2} & \\Phi\\!\\left(\\frac{\\mu_{D}-\\mu_{N}}{2\\sigma}\\right) & \\Phi\\!\\left(\\frac{\\mu_{D}-\\mu_{N}}{2\\sigma}\\right)\\end{pmatrix}}$$", "id": "2523986"}, {"introduction": "Next-generation sequencing (NGS) has revolutionized microbial diagnostics, yet its application to low-biomass samples introduces the critical challenge of distinguishing true pathogen signals from ubiquitous background contamination. A robust diagnostic workflow requires a formal method to handle this uncertainty, moving beyond simple ad-hoc thresholds that are prone to error. This advanced practice demonstrates how to construct a Bayesian statistical model that systematically incorporates evidence from negative controls to derive a principled decision rule for making reliable calls in a data-rich but noisy environment [@problem_id:2524024].", "problem": "A clinical metagenomic assay based on Next-Generation Sequencing (NGS) is used to screen low-biomass specimens for a focal bacterial taxon. To control for environmental and reagent contamination, the laboratory runs $m$ independent negative controls, each processed in parallel. Let $C_i$ denote the observed read count for the focal taxon in negative control $i$ with sequencing depth $E_i$ (in millions of reads), for $i \\in \\{1,\\dots,m\\}$. In a patient sample with depth $E_{\\mathrm{s}}$ (in millions of reads), let $K$ be the observed reads mapping to the focal taxon.\n\nAssume the following principles and model, grounded in standard probabilistic modeling for count data in microbial diagnostics:\n- Contaminant reads arise from a homogeneous Poisson process with per-exposure rate $\\theta$ (reads per million), so that $C_i \\mid \\theta \\sim \\mathrm{Poisson}(E_i \\,\\theta)$.\n- In the patient sample, under the null hypothesis $H_0$ (contaminant only), $K \\mid \\theta \\sim \\mathrm{Poisson}(E_{\\mathrm{s}} \\,\\theta)$. Under the alternative hypothesis $H_1$ (contaminant plus true signal), $K \\mid \\theta,\\phi \\sim \\mathrm{Poisson}(E_{\\mathrm{s}}\\,(\\theta+\\phi))$, where $\\phi$ is the per-exposure rate of true biological signal.\n- Use conjugate priors with a common rate parameter to reflect per-exposure scaling and to maintain analytical tractability: $\\theta \\sim \\mathrm{Gamma}(a_0,b_0)$ and $\\phi \\sim \\mathrm{Gamma}(a_{\\mathrm{s}}, b_{\\bullet})$, where $\\mathrm{Gamma}(a,b)$ denotes the gamma distribution with shape $a$ and rate $b$. After observing the negative controls, update the contamination prior to $\\theta \\mid \\{C_i,E_i\\}_{i=1}^m \\sim \\mathrm{Gamma}(a_c,b_c)$ with $a_c = a_0 + \\sum_{i=1}^m C_i$ and $b_c = b_0 + \\sum_{i=1}^m E_i$, and set $b_{\\bullet} = b_c$ so that $\\theta$ and $\\phi$ share the same rate.\n- Let $\\pi_1$ denote the prior probability that the focal taxon is truly present in the patient sample (so $\\mathbb{P}(H_1)=\\pi_1$ and $\\mathbb{P}(H_0)=1-\\pi_1$).\n\nFrom these foundations and without invoking any unmotivated shortcuts, derive a Bayesian decision rule that calls the taxon “present” if the posterior probability $\\mathbb{P}(H_1 \\mid K)$ is at least a target value $\\tau$. Your derivation must proceed from the Poisson likelihoods, the gamma priors, and Bayes’ theorem, explicitly integrating over the nuisance contamination rate $\\theta$ (and over $\\phi$ under $H_1$), and obtaining a closed-form Bayes factor in terms of $K$, $a_c$, $b_c$, $a_{\\mathrm{s}}$, and $E_{\\mathrm{s}}$.\n\nThen, apply your derived rule to the following scientifically realistic dataset and hyperparameters:\n- Negative controls: $m=4$, depths $(E_1,E_2,E_3,E_4)=(1,1,1,1)$, observed counts $(C_1,C_2,C_3,C_4)=(0,1,0,2)$.\n- Priors: $a_0=1$, $b_0=1$, $a_{\\mathrm{s}}=2$, and $\\pi_1=0.2$.\n- Patient sample: depth $E_{\\mathrm{s}}=2$.\n- Decision target: $\\tau=0.95$.\n\nCompute the smallest integer threshold $k^{\\star}$ such that declaring “present” when $K \\ge k^{\\star}$ achieves $\\mathbb{P}(H_1 \\mid K) \\ge \\tau$ under your decision rule. Provide only the value of $k^{\\star}$ as your final answer. No units are required, and no rounding instruction is necessary because $k^{\\star}$ is an integer by construction.", "solution": "We begin with the likelihood model based on Poisson processes scaled by exposure and gamma priors for conjugacy. The gamma density with shape $a$ and rate $b$ is\n$$\nf(x \\mid a,b) = \\frac{b^{a}}{\\Gamma(a)} x^{a-1} \\exp(-b x), \\quad x>0.\n$$\nFor negative controls, the contamination rate $\\theta$ has prior $\\theta \\sim \\mathrm{Gamma}(a_0,b_0)$. With independent observations $C_i \\mid \\theta \\sim \\mathrm{Poisson}(E_i \\theta)$, the joint likelihood is\n$$\nL(\\theta) \\propto \\prod_{i=1}^m \\exp(-E_i \\theta) (E_i \\theta)^{C_i} \\propto \\exp\\!\\Big(-\\theta \\sum_{i=1}^m E_i\\Big)\\, \\theta^{\\sum_{i=1}^m C_i}.\n$$\nCombining with the prior, the posterior for $\\theta$ is\n$$\n\\theta \\mid \\{C_i,E_i\\}_{i=1}^m \\sim \\mathrm{Gamma}\\!\\Big(a_c,b_c\\Big), \\quad a_c = a_0 + \\sum_{i=1}^m C_i,\\ \\ b_c = b_0 + \\sum_{i=1}^m E_i.\n$$\n\nIn the patient sample, under $H_0$ we have $K \\mid \\theta \\sim \\mathrm{Poisson}(E_{\\mathrm{s}} \\theta)$. The $\\mathrm{Gamma}$–$\\mathrm{Poisson}$ mixture yields a Negative Binomial (Poisson–Gamma) marginal:\n$$\np_0(K=k) \\equiv \\mathbb{P}(K=k \\mid H_0) = \\int_{0}^{\\infty} \\mathbb{P}(K=k \\mid \\theta)\\, f(\\theta \\mid a_c,b_c)\\, d\\theta.\n$$\nCarrying out the integral,\n$$\n\\mathbb{P}(K=k \\mid \\theta) = \\frac{(E_{\\mathrm{s}} \\theta)^k \\exp(-E_{\\mathrm{s}} \\theta)}{k!}, \\quad\nf(\\theta \\mid a_c,b_c) = \\frac{b_c^{a_c}}{\\Gamma(a_c)} \\theta^{a_c-1} \\exp(-b_c \\theta).\n$$\nThus\n$$\np_0(K=k) = \\frac{b_c^{a_c} E_{\\mathrm{s}}^{k}}{k!\\,\\Gamma(a_c)} \\int_{0}^{\\infty} \\theta^{k+a_c-1} \\exp\\!\\big(-(b_c+E_{\\mathrm{s}})\\theta\\big)\\, d\\theta\n= \\frac{b_c^{a_c} E_{\\mathrm{s}}^{k}}{k!\\,\\Gamma(a_c)} \\cdot \\frac{\\Gamma(k+a_c)}{(b_c+E_{\\mathrm{s}})^{k+a_c}}.\n$$\nRewriting with $p \\equiv \\frac{b_c}{b_c+E_{\\mathrm{s}}}$,\n$$\np_0(K=k) = \\frac{\\Gamma(k+a_c)}{k!\\,\\Gamma(a_c)} (1-p)^{k} p^{a_c},\n$$\nwhich is the Negative Binomial probability mass function with shape $a_c$ and success probability $p$.\n\nUnder $H_1$, we have $K \\mid \\theta,\\phi \\sim \\mathrm{Poisson}(E_{\\mathrm{s}}(\\theta+\\phi))$, with $\\theta \\sim \\mathrm{Gamma}(a_c,b_c)$ as above and $\\phi \\sim \\mathrm{Gamma}(a_{\\mathrm{s}}, b_{\\bullet})$ independent of $\\theta$. To preserve conjugacy and enable analytic marginalization, we set $b_{\\bullet}=b_c$. The sum of independent gamma variables sharing the same rate is also gamma with summed shapes and the same rate, so $\\theta+\\phi \\sim \\mathrm{Gamma}(a_c + a_{\\mathrm{s}}, b_c)$. Marginalizing over $(\\theta+\\phi)$ yields\n$$\np_1(K=k) \\equiv \\mathbb{P}(K=k \\mid H_1) = \\frac{\\Gamma(k+a_c+a_{\\mathrm{s}})}{k!\\,\\Gamma(a_c+a_{\\mathrm{s}})} (1-p)^{k} p^{a_c+a_{\\mathrm{s}}},\n$$\nwith the same $p = \\frac{b_c}{b_c+E_{\\mathrm{s}}}$.\n\nThe Bayes factor in favor of $H_1$ over $H_0$ for observing $K=k$ is\n$$\n\\mathrm{BF}(k) \\equiv \\frac{p_1(K=k)}{p_0(K=k)} = \\frac{\\Gamma(k+a_c+a_{\\mathrm{s}})}{\\Gamma(a_c+a_{\\mathrm{s}})} \\cdot \\frac{\\Gamma(a_c)}{\\Gamma(k+a_c)} \\cdot p^{a_{\\mathrm{s}}}.\n$$\nBy Bayes’ theorem, the posterior odds are\n$$\n\\mathrm{Odds}(H_1 \\mid K=k) = \\mathrm{BF}(k) \\times \\frac{\\pi_1}{1-\\pi_1},\n$$\nand the posterior probability is\n$$\n\\mathbb{P}(H_1 \\mid K=k) = \\frac{\\mathrm{Odds}(H_1 \\mid K=k)}{1 + \\mathrm{Odds}(H_1 \\mid K=k)}.\n$$\nA $(1-\\alpha)$ credible decision threshold $\\tau$ corresponds to requiring posterior odds at least $\\frac{\\tau}{1-\\tau}$. Thus, the Bayesian decision rule “call present” is\n$$\n\\text{Call present if } \\mathrm{BF}(k) \\times \\frac{\\pi_1}{1-\\pi_1} \\ge \\frac{\\tau}{1-\\tau}.\n$$\n\nWe now instantiate with the given data. First, update the contamination posterior from the negative controls. The controls have $m=4$, depths $(E_1,E_2,E_3,E_4)=(1,1,1,1)$, and counts $(C_1,C_2,C_3,C_4)=(0,1,0,2)$. With $a_0=1$ and $b_0=1$,\n$$\n\\sum_{i=1}^m C_i = 0+1+0+2 = 3, \\quad \\sum_{i=1}^m E_i = 1+1+1+1 = 4,\n$$\nso\n$$\na_c = a_0 + \\sum C_i = 1+3=4, \\quad b_c = b_0 + \\sum E_i = 1+4=5.\n$$\nSet $a_{\\mathrm{s}}=2$ and $b_{\\bullet}=b_c=5$, as specified. For the patient sample depth $E_{\\mathrm{s}}=2$,\n$$\np = \\frac{b_c}{b_c+E_{\\mathrm{s}}} = \\frac{5}{5+2} = \\frac{5}{7}.\n$$\nThus,\n$$\n\\mathrm{BF}(k) = \\frac{\\Gamma(k+4+2)}{\\Gamma(4+2)} \\cdot \\frac{\\Gamma(4)}{\\Gamma(k+4)} \\cdot \\left(\\frac{5}{7}\\right)^{2}.\n$$\nUsing $\\Gamma(4)=3!=6$ and $\\Gamma(6)=5!=120$ and the identity $\\frac{\\Gamma(k+6)}{\\Gamma(k+4)}=(k+5)(k+4)$, we obtain\n$$\n\\mathrm{BF}(k) = \\frac{(k+5)(k+4)}{20} \\cdot \\left(\\frac{5}{7}\\right)^{2} = \\frac{(k+5)(k+4)}{20} \\cdot \\frac{25}{49} = \\frac{25\\,(k+5)(k+4)}{980}.\n$$\nThe prior probability of true presence is $\\pi_1=0.2$, so the prior odds are\n$$\n\\frac{\\pi_1}{1-\\pi_1} = \\frac{0.2}{0.8} = \\frac{1}{4}.\n$$\nThe target posterior probability is $\\tau=0.95$, corresponding to a posterior odds threshold of\n$$\n\\frac{\\tau}{1-\\tau} = \\frac{0.95}{0.05} = 19.\n$$\nThe decision rule “call present” becomes\n$$\n\\mathrm{BF}(k) \\times \\frac{1}{4} \\ge 19 \\quad \\Longleftrightarrow \\quad \\mathrm{BF}(k) \\ge 76.\n$$\nSubstitute the closed-form Bayes factor:\n$$\n\\frac{25\\,(k+5)(k+4)}{980} \\ge 76 \\quad \\Longleftrightarrow \\quad (k+5)(k+4) \\ge 76 \\cdot \\frac{980}{25}.\n$$\nCompute the right-hand side exactly:\n$$\n\\frac{980}{25} = \\frac{196}{5}, \\quad 76 \\cdot \\frac{196}{5} = \\frac{76 \\cdot 196}{5} = \\frac{14896}{5} = 2979.2.\n$$\nTherefore, we require\n$$\n(k+5)(k+4) \\ge 2979.2.\n$$\nSince $(k+5)(k+4)$ is an integer, the smallest integer satisfying this is the smallest $k$ such that $(k+5)(k+4) \\ge 2980$. Evaluate near the quadratic root:\n$$\nk=50 \\Rightarrow (55)(54)=2970 \\quad (\\text{insufficient}), \\quad k=51 \\Rightarrow (56)(55)=3080 \\quad (\\text{sufficient}).\n$$\nHence, the minimal threshold is\n$$\nk^{\\star} = 51.\n$$\nDeclaring “present” when $K \\ge 51$ ensures $\\mathbb{P}(H_1 \\mid K) \\ge 0.95$ under the stated Bayesian contamination model and priors.", "answer": "$$\\boxed{51}$$", "id": "2524024"}]}